Phio Pharmaceuticals
PHIO
PHIO
14 hedge funds and large institutions have $415K invested in Phio Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
14
Holding in Top 10
–
Calls
$36K
Puts
–
Top Buyers
| 1 | +$12.8K | |
| 2 | +$8.71K | |
| 3 | +$8.48K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$7.04K |
| 5 |
VF
Virtu Financial
New York
|
+$2.88K |
Top Sellers
| 1 | -$56K | |
| 2 | -$14.9K | |
| 3 | -$3.18K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.89K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$303 |